| Description | Anatumomab mafenatox (ABR-214936), a 73 KDa recombinant protein, targets the tumor-associated antigen 5T4 commonly expressed in malignancies. It is a conjugate comprising a modified form of SEA linked to a murine Fab. The primary adverse effects of Anatumomab mafenatox include fever, hypotension, pain, nausea, and drowsiness [1]. |
| Synonyms | ABR-214936 |
| molecular weight | N/A |
| CAS | 1370261-50-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |